Biomarkers for predicting response to tyrosine kinase inhibitors in drug-sensitive and drug-resistant human bladder cancer cells. [electronic resource]
- Oncology reports Feb 2015
- 951-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1791-2431
10.3892/or.2014.3639 doi
Adenosine Triphosphate--chemistry Antineoplastic Agents--chemistry Biomarkers, Tumor--metabolism Cell Line, Tumor Drug Resistance, Neoplasm Gefitinib Genes, p53 Humans Lapatinib Mitogen-Activated Protein Kinase 1--metabolism Mitogen-Activated Protein Kinase 3--metabolism Mutation Phosphorylation Protein Kinase Inhibitors--chemistry Quinazolines--chemistry Receptor, ErbB-2--metabolism Signal Transduction Urinary Bladder Neoplasms--genetics